Penumbra Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $288.06
- Today's High:
- $298.97
- Open Price:
- $298.97
- 52W Low:
- $144.76
- 52W High:
- $348.67
- Prev. Close:
- $300.02
- Volume:
- 402300
Company Statistics
- Market Cap.:
- $11.53 billion
- Book Value:
- 27.771
- Revenue TTM:
- $937.79 million
- Operating Margin TTM:
- 3.86%
- Gross Profit TTM:
- $535.21 million
- Profit Margin:
- 3.11%
- Return on Assets TTM:
- 1.64%
- Return on Equity TTM:
- 2.86%
Company Profile
Penumbra Inc had its IPO on 2015-09-18 under the ticker symbol PEN.
The company operates in the Healthcare sector and Medical Devices industry. Penumbra Inc has a staff strength of 3,900 employees.
Stock update
Shares of Penumbra Inc opened at $298.97 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $288.06 - $298.97, and closed at $290.22.
This is a -3.27% slip from the previous day's closing price.
A total volume of 402,300 shares were traded at the close of the day’s session.
In the last one week, shares of Penumbra Inc have increased by +9.88%.
Penumbra Inc's Key Ratios
Penumbra Inc has a market cap of $11.53 billion, indicating a price to book ratio of 8.7743 and a price to sales ratio of 10.1238.
In the last 12-months Penumbra Inc’s revenue was $937.79 million with a gross profit of $535.21 million and an EBITDA of $60.42 million. The EBITDA ratio measures Penumbra Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Penumbra Inc’s operating margin was 3.86% while its return on assets stood at 1.64% with a return of equity of 2.86%.
In Q2, Penumbra Inc’s quarterly earnings growth was a positive 10684.3% while revenue growth was a positive 25.5%.
Penumbra Inc’s PE and PEG Ratio
- Forward PE
- 277.7778
- Trailing PE
- 384.641
- PEG
- -62.27
Its diluted EPS in the last 12-months stands at $0.78 per share while it has a forward price to earnings multiple of 277.7778 and a PEG multiple of -62.27. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Penumbra Inc’s profitability.
Penumbra Inc stock is trading at a EV to sales ratio of 10.3348 and a EV to EBITDA ratio of -565.2134. Its price to sales ratio in the trailing 12-months stood at 10.1238.
Penumbra Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $1.43 billion
- Total Liabilities
- $144.12 million
- Operating Cash Flow
- $-6671000.00
- Capital Expenditure
- $4.34 million
- Dividend Payout Ratio
- 0%
Penumbra Inc ended 2024 with $1.43 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $1.43 billion while shareholder equity stood at $1.07 billion.
Penumbra Inc ended 2024 with $0 in deferred long-term liabilities, $144.12 million in other current liabilities, 38000.00 in common stock, $71.43 million in retained earnings and $166.17 million in goodwill. Its cash balance stood at $114.17 million and cash and short-term investments were $221.06 million. The company’s total short-term debt was $12,699,000 while long-term debt stood at $0.
Penumbra Inc’s total current assets stands at $827.88 million while long-term investments were $0 and short-term investments were $106.90 million. Its net receivables were $208.97 million compared to accounts payable of $25.82 million and inventory worth $358.77 million.
In 2024, Penumbra Inc's operating cash flow was $-6671000.00 while its capital expenditure stood at $4.34 million.
Comparatively, Penumbra Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $290.22
- 52-Week High
- $348.67
- 52-Week Low
- $144.76
- Analyst Target Price
- $344.36
Penumbra Inc stock is currently trading at $290.22 per share. It touched a 52-week high of $348.67 and a 52-week low of $348.67. Analysts tracking the stock have a 12-month average target price of $344.36.
Its 50-day moving average was $283.39 and 200-day moving average was $273.23 The short ratio stood at 4.65 indicating a short percent outstanding of 0%.
Around 390.1% of the company’s stock are held by insiders while 9249.7% are held by institutions.
Frequently Asked Questions About Penumbra Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Penumbra, Inc., together with its subsidiairies, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, SENDit, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System, Lightning, and CAT RX brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and POD (Penumbra Occlusion Device) brand, as well as immersive 3D computer-based technology platform under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.